Jefferies Group’s Esperion Therapeutics ESPR Stock Holding History

Jefferies Group’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-50,000	Closed	-$1.4M	–	1756
2021 Q1	$1.4M	Buy	+50,000	New	+$1.48M	0.01%	792
2019 Q4	–	Sell	-17,600	Closed	-$645K	–	2661
2019 Q3	$645K	Hold	17,600	–	–	0.01%	1749
2019 Q2	$819K	Buy	+17,600	New	+$827K	0.01%	1400
2018 Q4	–	Sell	-15,000	Closed	-$666K	–	2256
2018 Q3	$666K	Buy	15,000 +2,500	+20%	+$115K	﹤0.01%	1513
2018 Q2	$490K	Buy	+12,500	New	+$632K	﹤0.01%	1608
2015 Q2	–	Sell	-30,000	Closed	-$2.78M	–	3345
2015 Q1	$2.78M	Hold	30,000	–	–	0.02%	624
2014 Q4	$1.21M	Buy	+30,000	New	+$918K	0.01%	897

Other funds holding ESPR

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return